We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia
Packaging Information: 25kg/drum
Delivery Lead Time: 1 week
Sample Provided: yes
Payment Terms: T/T
Name: Rutin CAS#: 153-18-4 Botanical Source: Sophora Japonica Specification:NF11, DAB, EP, Powder or Granule Function & Application: Nutrition human and decrease capillary fragility
TEST ITEM
STANDARD
RESULT
Appearance
Yellow or greenish-yellow, crystalline powder
Complies (Visual)
Melting point
195℃
Complies(Melting point apparatus)
Identification
(a)(b)(c) Positive reaction
Complies
Solubility
- in water
Soluble slightly
Complies
- in methanol
Soluble freely
Complies
- in alkaline solutions
Soluble freely
Complies
- in chloroform
Insloluble
Complies
Loss on drying
5.5%---9.0%
Complies
Residue on ignition
≤0.5%
Complies
Quercetin
≤0.4%
Complies
Assay
95%---101.5%
Complies (HPLC/UV)
HEAVY METAL
STANDARD
RESULT(ICP-MS)
Lead
≤3ppm
Complies
Cadmium
≤1ppm
Complies
Mercury
≤0.1ppm
Complies
Arsenic
≤1ppm
Complies
MICROBIOLOGICAL TEST
STANDARD
RESULT
Total microbial count
≤1000cfu/g
Complies
Yeast & mold
≤100cfu/g
Complies
E.Coli
Negative
Negative
Salmonella
Negative
Negative
Packaging: The usual packaging is 25kg net carton drum or box with a polyethylene bag in side. Storage: Preserve in well closed,light resistant and dry environment.
Audited Supplier
Pharma Sources Insight JANUARY 2024
